Crystalline FRAP complex

The invention relates to the human protein FRAP, and in particular to the FKBP12-rapamycin binding domain thereof and to the ternary complex formed by the FRB domain, rapamycin and FKBP12. A new crystalline composition comprising the ternary complex, coordinates defining its three dimensional structure in atomic detail, and uses thereof are disclosed.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. An orthorhombic crystalline composition in the space group P2.sub.1 2.sub.1 2.sub.1 which diffracts X-rays at a resolution of 2.7.ANG. or better, each asymmetric unit of which containing one complex comprising:

(a) a first protein comprising a peptide sequence derived or selected from the peptide sequence of human FK506 binding protein 12 (FKBP12),
(b) a second protein comprising a peptide sequence derived or selected from the peptide sequence of an FKBP:rapamycin binding domain of human FKBP:Rapamycin Associated Protein (FRAP), and
(c) rapamycin or a rapamycin derivative capable of forming a ternary complex with the first and second proteins.

2. The crystalline composition of claim 1, wherein the first protein comprises the peptide sequence of SEQ ID No. 1 and the second protein comprises the peptide sequence of SEQ ID No. 2.

3. The composition of any of claims 1 or 2 in which the proteins of the complex are characterized by the coordinates of FIG. 4, or by coordinates having a root mean square deviation therefrom, with respect to conserved backbone atoms of the listed amino acids, of not more than 1.5.ANG..

Referenced Cited
Other references
  • Choi et al. "Structure of the FKBP12-Rapamycin complex interacting with the binding domain of human FRAP" Science 273, 239-242, Jul. 12, 1996. Van Duyne "Atomic structure of the human immunophilin FKBP-12 complex with FK506 and rapamycin" J. Mol. Biol. 229, 105-124, 1993. Wilson et al. Comparative X-ray structure of the major binding protein for the immunosuppressant FK506 . . . Acta Cryst. D51, 551-521, 1995.
Patent History
Patent number: 5939528
Type: Grant
Filed: Oct 31, 1997
Date of Patent: Aug 17, 1999
Assignee: Cornell Research Foundation, Inc. (Ithaca, NY)
Inventors: Jon C. Clardy (Ithaca, NY), Jungwon Choi (Seoul)
Primary Examiner: Robert A. Wax
Assistant Examiner: Nashaat T. Nashed
Attorney: David L. Berstein
Application Number: 8/963,601
Classifications
Current U.S. Class: Proteins, I.e., More Than 100 Amino Acid Residues (530/350); 536/231; 536/235
International Classification: C07K 1447;